Commensal bacteria stimulate antitumor responses via T cell cross-reactivity CA Bessell, A Isser, JJ Havel, S Lee, DR Bell, JW Hickey, ... JCI insight 5 (8), 2020 | 129 | 2020 |
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy A Isser, NK Livingston, JP Schneck Biomaterials 268, 120584, 2021 | 56 | 2021 |
Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by nanoscale artificial antigen-presenting cells J Ichikawa, T Yoshida, A Isser, AS Laino, M Vassallo, D Woods, S Kim, ... Clinical Cancer Research 26 (13), 3384-3396, 2020 | 37 | 2020 |
Collagen fiber architecture regulates hypoxic sarcoma cell migration DM Lewis, V Tang, N Jain, A Isser, Z Xia, S Gerecht ACS Biomaterials Science & Engineering 4 (2), 400-409, 2018 | 30 | 2018 |
Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma KR Rhodes, A Isser, JW Hickey, E Ben-Akiva, RA Meyer, AK Kosmides, ... ACS applied materials & interfaces 13 (7), 7913-7923, 2021 | 26 | 2021 |
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties JW Hickey, AY Isser, FP Vicente, SB Warner, HQ Mao, JP Schneck Biomaterials 187, 105-116, 2018 | 26 | 2018 |
Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific T cells JW Hickey, A Isser, SF Salathe, KM Gee, MH Hsiao, W Shaikh, ... Nano letters 20 (9), 6289-6298, 2020 | 22 | 2020 |
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy E Ben-Akiva, JW Hickey, RA Meyer, A Isser, SR Shannon, NK Livingston, ... Acta biomaterialia 160, 187-197, 2023 | 14 | 2023 |
Cross-reactivity of SARS-CoV-2–and influenza A–specific T cells in individuals exposed to SARS-CoV-2 W Chaisawangwong, H Wang, T Kouo, SF Salathe, A Isser, JG Bieler, ... JCI insight 7 (18), 2022 | 12 | 2022 |
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy A Isser, AB Silver, HC Pruitt, M Mass, EH Elias, G Aihara, SS Kang, ... Nature communications 13 (1), 6086, 2022 | 11 | 2022 |
Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. Jci Insight 5, e135597 CA Bessell, A Isser, JJ Havel, S Lee, DR Bell, JW Hickey, ... | 6 | 2020 |
High-affinity T cell receptors for adoptive cell transfer A Isser, JP Schneck The Journal of Clinical Investigation 129 (1), 69-71, 2019 | 2 | 2019 |
Using nanoparticles as artificial antigen presenting cells to mobilize CD4 T cells for immunotherapy. SS Kang, A Isser, JP Schneck The Journal of Immunology 210 (1_Supplement), 250.12-250.12, 2023 | 1 | 2023 |
A conserved MART-1 T cell receptor motif is predictive of responses to checkpoint blockade A Isser, T Yoshida, J Ichikawa, J Weber, J Schneck JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 1 | 2019 |
Particle elasticity influences polymeric artificial antigen presenting cell effectiveness in vivo via CD8+ T cell activation, macrophage uptake, and the protein corona SE Est-Witte, SR Shannon, DH Gong, KG Calabresi, JJ Harris, K Storm, ... Nano Research, 1-13, 2024 | | 2024 |
1215 Using nanoparticles as artificial antigen presenting cells to activate human CD4 T cells for immunotherapy SS Kang, A Isser, J Schneck Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific t cells J Schneck, H Mao, JW Hickey, A Isser US Patent App. 18/011,070, 2023 | | 2023 |
TARGETING CD4 T CELLS WITH NANOTECHNOLOGY FOR ENHANCED CANCER IMMUNOTHERAPY AY Isser Johns Hopkins University, 2022 | | 2022 |
Cross Reactivity of CD8+ T Cell Neo-epitopes to Bifidobacterium Boosts the Tumor Specific Population CA Bessell, A Isser, J Havel, T Chan, JP Schneck The Journal of Immunology 200 (1_Supplement), 57.33-57.33, 2018 | | 2018 |